The number of IBD patients who find themselves with colorectal cancer has decreased over the past ten years due to better screening tools and medication. And to help continue that trend, Dr. Animesh Jain and Dr. David Hudesman discuss the unique risk factors and the importance of early screening at the second annual Crohn’s & Colitis Congress in Las Vegas.
Release Date: 04/02/2019
- Health Maintenance
Practical Pearls and Navigating Barriers to Advanced IBD Therapeutics
Anh-Thu Truong, PharmDPeer